Vancouver General Hospital, Vancouver, British Columbia, Canada.
Am Heart J. 2013 Jul;166(1):38-44. doi: 10.1016/j.ahj.2013.03.015. Epub 2013 Apr 29.
We comparatively evaluated clinical outcomes in men and women presenting with stable angina with no coronary artery disease (CAD), nonobstructive CAD, and obstructive CAD on coronary angiography.
We studied all patients ≥20 years with stable angina, undergoing coronary angiography in British Columbia, Canada, from July 1999 to December 2002 (n = 13,695) with maximum follow-up to 3 years. No CAD, nonobstructive CAD, and obstructive CAD were defined as 0%, 1% to 49%, and ≥50% luminal narrowing in any epicardial coronary artery, respectively. Freedom from major adverse cardiac events (MACEs), which included the combined end points of all-cause mortality, nonfatal acute myocardial infarction, nonfatal stroke, and heart failure admissions, was estimated using the Kaplan-Meier method. Hazard ratios (HRs) and 95% CIs for MACE were estimated up to 3 years postcatheterization and compared between sex and CAD groups.
Within the first year, women with nonobstructive CAD had a higher risk of MACE than men with nonobstructive CAD (adjusted HR 2.43, 95% CI 1.08-5.49). Furthermore, women with nonobstructive CAD had a 2.55-fold higher risk of MACE than women with no CAD (95% CI 1.33-4.88). In contrast, men with nonobstructive CAD had a similar risk as men with no CAD (adjusted HR 0.61, 95% CI 0.26-1.45). The differences in MACE according to extent of CAD were not evident in the longer term.
Women with stable angina and nonobstructive CAD are 3 times more likely to experience a cardiac event within the first year of cardiac catheterization than men. A prospective trial to examine the impact of medical therapy on MACE in patients with nonobstructive CAD is warranted.
我们比较了在冠状动脉造影中无冠状动脉疾病 (CAD)、非阻塞性 CAD 和阻塞性 CAD 的稳定型心绞痛男性和女性患者的临床结局。
我们研究了所有在加拿大不列颠哥伦比亚省 1999 年 7 月至 2002 年 12 月期间因稳定型心绞痛而接受冠状动脉造影的≥20 岁患者(n=13695),最长随访时间为 3 年。无 CAD、非阻塞性 CAD 和阻塞性 CAD 分别定义为任何心外膜冠状动脉的管腔狭窄程度为 0%、1%至 49%和≥50%。使用 Kaplan-Meier 方法估计无主要不良心脏事件 (MACE)的生存率,MACE 包括全因死亡率、非致死性急性心肌梗死、非致死性卒中和心力衰竭入院的联合终点。在导管插入术后 3 年内,使用风险比 (HR) 和 95%置信区间 (CI) 估计 MACE,并比较性别和 CAD 组之间的 HR。
在第一年,非阻塞性 CAD 的女性患者发生 MACE 的风险高于非阻塞性 CAD 的男性患者(调整后的 HR 2.43,95%CI 1.08-5.49)。此外,非阻塞性 CAD 的女性患者发生 MACE 的风险是无 CAD 女性患者的 2.55 倍(95%CI 1.33-4.88)。相比之下,非阻塞性 CAD 的男性患者发生 MACE 的风险与无 CAD 的男性患者相似(调整后的 HR 0.61,95%CI 0.26-1.45)。在较长时间内,根据 CAD 程度的不同,MACE 的差异并不明显。
在心脏导管插入术的第一年,患有稳定型心绞痛和非阻塞性 CAD 的女性患者发生心脏事件的可能性是男性患者的 3 倍。需要进行一项前瞻性试验,以检查非阻塞性 CAD 患者的药物治疗对 MACE 的影响。